| Quarterly Financials | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 |
Revenue  | 41 | 20 | 18 | 25 | 27 | 26 | 27 | 26 | 28 |
| Expenses | 36 | 18 | 16 | 23 | 25 | 23 | 25 | 23 | 25 |
| EBITDA | 4 | 2 | 3 | 3 | 2 | 3 | 2 | 3 | 3 |
| Operating Profit % | 9 % | 9 % | 13 % | 9 % | 8 % | 10 % | 4 % | 9 % | 8 % |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 1 |
| Profit Before Tax | 2 | 1 | 1 | 2 | 1 | 2 | 0 | 1 | 1 |
| Tax | 1 | 0 | 0 | 0 | 0 | 1 | -1 | -0 | 1 |
| Net Profit | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 1 |
| EPS in ₹ | 4.41 | 0.29 | 1.58 | 1.01 | 0.58 | 0.82 | 1.49 | 1.32 | 0.42 |
Sotac Pharmaceuticals
Sotac Pharmaceuticals
111.30
0.00
(0.00%)
Market Cap
122.99 Cr
PE Ratio
13.27
Volume
0.00
Day High - Low
- - -
52W High-Low
152.35 - 100.00
Key Fundamentals
Market Cap
122.99 Cr
EPS
7.26
PE Ratio
13.27
PB Ratio
2.31
Book Value
48.19
EBITDA
17.50
Dividend Yield
0.00 %
Industry
Healthcare Sector
Pharmaceuticals Return on Equity
15.88
Debt to Equity
0.70
Actual
Company News
View All News
Sotac Pharmaceuticals Limited confirms no encumbrance on promoter shares for FY 2025-26. The declaration was submitted under SEBI Regulation 31(4).
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,845.00 | #1 4,42,677.30 | 40.42 | #1 58,220.10 | 6.38 | #1 11,565 | 25.80 | 54.75 | |
6,850.50 | 1,81,859.25 | 73.73 | 10,560.00 | 8.73 | 2,520 | 13.44 | 66.48 | |
4,655.90 | 1,57,576.81 | 66.80 | 13,753.00 | 19.18 | 2,028 | -26.91 | 61.90 | |
1,400.00 | 1,13,089.29 | 29.26 | 27,711.70 | -2.46 | 3,783 | -55.32 | 61.92 | |
1,300.30 | 1,08,528.63 | 26.24 | 33,593.30 | -0.44 | 3,998 | -86.05 | 52.61 | |
1,054.05 | 1,06,062.09 | 20.40 | 26,719.70 | 13.65 | 5,242 | 7.82 | 69.40 | |
2,276.50 | 1,04,045.89 | #1 19.46 | 27,487.50 | 19.98 | 5,345 | #1 87.72 | 47.33 | |
2,472.80 | 1,02,078.44 | 52.84 | 14,277.60 | 12.03 | 1,750 | 31.75 | 62.34 | |
1,450.00 | 84,216.24 | 24.29 | 33,384.70 | 3.21 | 3,376 | 1.99 | 52.91 | |
1,349.40 | 72,848.25 | 81.46 | 6,812.90 | #1 21.03 | 884 | 21.18 | 77.10 |
Growth Rate
Revenue Growth
-3.26 %
Net Income Growth
158.33 %
Cash Flow Change
73.07 %
ROE
118.73 %
ROCE
104.57 %
EBITDA Margin (Avg.)
101.39 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2020 | 2021 | 2023 | 2024 | 2025 |
| Total Assets | 30 | 35 | 74 | 105 | 124 |
| Fixed Assets | 16 | 17 | 26 | 36 | 49 |
| Current Assets | 14 | 17 | 47 | 61 | 70 |
| Capital Work in Progress | 0 | 0 | 0 | 5 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 14 | 18 | 48 | 65 | 75 |
| Total Equity & Liabilities | 30 | 35 | 74 | 105 | 124 |
| Current Liabilities | 19 | 23 | 46 | 44 | 52 |
| Non Current Liabilities | 6 | 9 | 8 | 12 | 14 |
| Total Equity | 5 | 3 | 20 | 49 | 58 |
| Reserve & Surplus | 1 | 0 | 2 | 34 | 42 |
| Share Capital | 2 | 2 | 8 | 11 | 11 |
Cash Flow
| Cash Flow | 2020 | 2021 | 2023 | 2024 | 2025 |
| Net Cash Flow | -0 | -0 | 10 | -6 | -2 |
| Investing Activities | -12 | -3 | -12 | -20 | -14 |
| Operating Activities | 0 | -0 | 8 | -16 | -4 |
| Financing Activities | 11 | 3 | 13 | 30 | 16 |
Share Holding
| % Holding | Apr 2023 | Sept 2023 | Mar 2024 | Sept 2024 | Mar 2025 | Sept 2025 | Mar 2026 |
| Promoter | 72.85 % | 72.85 % | 72.85 % | 72.85 % | 72.85 % | 72.85 % | 72.85 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 16.79 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 8.19 % | 5.32 % | 5.82 % | 6.01 % | 4.70 % | 5.13 % | 6.52 % |
| Others | 18.96 % | 21.83 % | 21.33 % | 21.14 % | 22.45 % | 22.02 % | 3.84 % |
| No of Share Holders | 784 | 255 | 245 | 251 | 243 | 240 | 221 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 26 May 2026 |  Quarterly Result Announcement | NA | 26 May 2026 | 111.30 | 111.30 |
| 27 Sept 2024 |  Annual General Meeting | NA | 27 Sept 2024 | 154.95 | 135.55 |
| 29 Oct 2024 | Quarterly Result Announcement | NA | 29 Oct 2024 | 136.80 | 130.00 |
| 28 May 2025 | Quarterly Result Announcement | NA | 28 May 2025 | 120.65 | 120.40 |
| 19 Sept 2025 |  Dividend | ₹ 0.10 /share | 19 Sept 2025 | 120.40 | 121.80 |
| 12 Nov 2025 | Quarterly Result Announcement | NA | 12 Nov 2025 | 129.85 | 129.00 |
Technical Indicators
RSI(14)
Neutral 51.79
ATR(14)
Less Volatile 3.28
STOCH(9,6)
Neutral 30.56
STOCH RSI(14)
Neutral 64.89
MACD(12,26)
Bullish 0.84
ADX(14)
Weak Trend 9.29
UO(9)
Bearish 51.08
ROC(12)
Uptrend And Accelerating 9.93
WillR(14)
Neutral -36.19
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
